Skip to content
Drug recall · FDA · Published October 20, 2023

ITF PHARMA INC recalls Tiglutik (riluzole) Oral Suspension 50 mg/10 mL (5 mg/mL), 600 mL (two bottles/300 mL each), RX only, Manufactured for

ITF Pharma recalls Tiglutik oral suspension (50 mg/10 mL) due to failed viscosity tests. This medication is prescription-only and may not mix properly, affecting dosing accuracy.

🇺🇸 FDA recall #D-0115-2024DrugITF Pharma ›
Take action

Contact the company & request your remedy

Recalling firmITF PHARMA INC850 Cassatt Rd, N/A · Berwyn, PA 19312-2701
No email on file for this recall — reach the company by phone or its official page instead.No email on file — write to the address above instead.
✎ GovInfoNow plain-language explainer

What happened, in plain English

ITF Pharma is recalling Tiglutik oral suspension because it failed viscosity tests. This means the suspension might not mix properly, leading to incorrect dosing for patients using it as prescribed. Read more at govinfonow.com/recall/33040-itf-pharma-recalls-tiglutik-oral-suspension-due-to-viscosity-issues.

Source Summary by GovInfoNow · govinfonow.com/recall/33040-itf-pharma-recalls-tiglutik-oral-suspension-due-to-viscosity-issues · Updated September 23, 2026 · FDA enforcement record: FDA #D-0115-2024

Cite this page

“ITF Pharma Recalls Tiglutik Oral Suspension Due to Viscosity Issues.” GovInfoNow, updated September 23, 2026. https://govinfonow.com/recall/33040-itf-pharma-recalls-tiglutik-oral-suspension-due-to-viscosity-issues. Based on FDA recall #D-0115-2024 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0115-2024%22&limit=1).

Why it’s dangerous

The suspension failed viscosity tests, meaning it may not mix properly. This could lead to incorrect dosing if the medication is not properly mixed before use, potentially affecting treatment effectiveness.

Who’s affected

Prescription patients using Tiglutik oral suspension (50 mg/10 mL) manufactured by ITF Pharma. Those with specific lot numbers are most at risk.

How to tell if you have this one

Check for the product name 'Tiglutik (riluzole) Oral Suspension 50 mg/10 mL (5 mg/mL), 600 mL (two bottles/300 mL each)'. Look for lot numbers 2231901 (expiring 11/30/2025) or 2307901 (expiring 03/31/2026).

  • Brand
    ITF Pharma
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Product Details

    Verify the lot number and expiration date on the packaging to confirm if your product is affected.

✎ GovInfoNow

Questions people ask

Is this medication safe to use?

The recall is due to failed viscosity tests, which may affect dosing accuracy. It is not safe to use as intended without checking the recall status.

What should I do if I have this medication?

Check the lot number on the packaging. If it matches 2231901 (expiring 11/30/2025) or 2307901 (expiring 03/31/2026), contact ITF Pharma for instructions.

Is there a risk of serious injury?

The hazard is related to potential dosing errors, not direct injury. The risk level is low as the issue affects medication accuracy, not immediate safety.

Take action

Contact ITF Pharma

We’ve drafted a message you can send ITF Pharma to request your refund or repair — edit it as you like.

Subject: Recall D-0115-2024 — ITF Pharma ITF Pharma

Hello,

I own a ITF Pharma that is covered by recall D-0115-2024 from ITF Pharma.

I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this?

Thank you.

Similar recalls

Keep exploring

From people who’ve dealt with this

Experiences, tips, and questions from readers. Every comment is reviewed before it appears.

No comments yet — be the first to share your experience.

Comments are reviewed before they appear. No links, ads, or personal attacks — those get removed.

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0115-2024 (October 20, 2023) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0115-2024 to see it in context.
  • Plain-language summary written by qwen3:4b on September 23, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA